SAN ANTONIO--(BUSINESS WIRE)--Xilas Medical, Inc. announced the publication of its results from its Phase II clinical trial designed to evaluate the effectiveness of its TempTouch home infrared temperature probe to reduce the incidence of diabetic foot ulcers among high-risk patients.
